Consistent absorption, easier injection
Real-world dosing and outcomes 6-month persister loss about 12-13% (Hankosky DOM 2025), broad-cohort about -9.8% (Adamidis Cureus 2026), telehealth completers near -23% (Duncan Obesity Pillars 2026)
Our experienced providers ensure treatments are effective, safe, and part of a supportive wellness journey
Pediatrics Safety has not been established GHK-Cu is a naturally occurring copper-binding tripeptide composed of glycine (G), histidine (H), and lysine (K)
The effect of oxidative stress has been associated with the absolute quantity and the type of macronutrients consumed [14]
Our 5mg BPC-157 vials are manufactured to strict standards in a US-based, ISO-certified facility